Zobrazeno 1 - 10
of 84
pro vyhledávání: '"V. A. Korneva"'
Publikováno v:
Медицинская иммунология, Vol 24, Iss 2, Pp 273-282 (2022)
Impaired balance of T regulatory and T effector lymphocytes has recently been considered as an important pathogenetic link in arterial hypertension (AH). There are, however, contradictory literature data about contents of these cells in the patients
Externí odkaz:
https://doaj.org/article/a4afa794f400419a82d40e8aa819f73c
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 42-47 (2020)
Aim: to evaluate the efficacy and safety of the use of evolocumab in patients with familial hypercholesterolemia (FH).Materials and methods: Fifteen patients with a definite FH were treated with PCSK9 inhibitors, in 11 patients with a history of CAD.
Externí odkaz:
https://doaj.org/article/33ddb48bdbf844e18acabc04ce13f94c
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 24, Iss 1, Pp 96-101 (2020)
The levels of plasma interleukin 6 and its soluble receptors were found to be elevated in subjects with cardiovascular diseases, which points to amplification of the IL-6-mediated trans-signaling pathway in cells and the development of chronic inflam
Externí odkaz:
https://doaj.org/article/9a49eab5a1b642ad9ad83db76fc9901b
Autor:
A. S. Alieva, O. V. Reutova, E. I. Pavlyuk, D. V. Duplyakov, A. V. Khripun, I. P. Efimova, Yu. A. Guryanova, E. S. Timoshchenko, A. A. Nekrasov, A. M. Namitokov, V. K. Zafiraki, E. D. Kosmacheva, V. A. Korneva, N. N. Vezikova, I. S. Skopets, N. E. Zvartau, E. V. Shlyakhto
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 6 (2021)
Despite the advances in lipidology over the past decade, the control of dyslipidemia at the population level in Russia, as in a number of European countries, remains unsatisfactory. The need for novel organizational approaches to solving the problem
Externí odkaz:
https://doaj.org/article/ca83f2d712cf443ba600a0fafe769c7e
Autor:
M. V. Yezhov, S. A. Bliznyuk, N. A. Tmoyan, T. A. Rozhkova, D. V. Duplyakov, V. A. Salchenko, M. A. Kachkovsky, I. I. Shaposhnik, V. V. Genkel, V. S. Gurevich, S. А. Urazgildeeva, A. V. Tregubov, M. V. Muzalevskaya, S. S. Bazhan, O. V. Timoshchenko, I. A. Urvantseva, K. G. Kozhokar, A. A. Sokolov, V. V. Tishko, O. I. Boyeva, E. V. Bolotova, A. M. Namitokov, Yu. B. Kushnaryova, T. Yu. Kuznetsova, V. A. Korneva, D. Yu. Bogdanov, E. E. Chichina, V. M. Solovyov, A. I. Ershova, A. N. Meshkov, V. I. Makogonenko, A. S. Galyavich, D. I. Sadykova, B. V. Pomogaybo, O. L. Barbarash, V. V. Kashtalap, E. A. Shutemova, I. G. Isaeva, R. A. Khokhlov, V. E. Oleynikov, I. V. Avdeeva, V. V. Malakhov, U. V. Chubykina, V. O. Konstantinov, A. S. Aliyeva, V. V. Ovsyannikova, G. I. Furmenko, T. M. Chernykh, O. E. Abashina, A. R. Dzhanibekova, E. S. Slastnikova, L. F. Galimova, P. D. Duplyakova, M. I. Voyevoda
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 7-13 (2019)
Aim. Russian multicenter register of familial hypercholesterolemia (FH) was transformed into Register of patients with FH and very high cardiovascular risk with insufficient effect of hypolipidemic therapy (RENESSANS Registry) in 2017 The aim of RENE
Externí odkaz:
https://doaj.org/article/d539699873c94e3aa2400b582c255079
Publikováno v:
Медицинский совет, Vol 0, Iss 17, Pp 253-260 (2018)
Homozygous familial hypercholesterolemia is a rare genetic disease featuring extremely high of low-density lipoprotein blood level, cutaneous and tendon xanthomas and accelerated atherosclerosis with often manifestions in the first 2 decades of life,
Externí odkaz:
https://doaj.org/article/ea149d6de65d4c53b98458063ed88a23
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 104-110 (2017)
Familial hypercholesterolemia (FH) is inherited pathology with increased level of cholesterol, and predisposes for early development of atherosclerosis, but prevalence of cardiovascular pathology in FH patients varies, and demands for more precise de
Externí odkaz:
https://doaj.org/article/fc5ce8e5085944ad90187ac245f1067b
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 45-49 (2016)
Aim. To analyze the relation of Lp(a) and atherosclerosis development in familial hypercholesterolemia (FHCE).Material and methods. Totally, 81 patient with definite FHCE studied, mean age 39,1±0,4 y. o. The participants were selected to two groups:
Externí odkaz:
https://doaj.org/article/69f6bae9e0294907900affee3996687b
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 11, Iss 4, Pp 380-384 (2015)
Cardiovascular diseases remain the most common cause of death in Russia. In real clinical practice doctors are more focused on the modification of other major risk factors rather than on the correction of dyslipidemia, or pay more attention to second
Externí odkaz:
https://doaj.org/article/57d1146f87ed48e7b8922ea6c2a55253
Autor:
V. A. Korneva, T. Yu. Kuznetsova, T. Yu. Bogoslovskaya, R. Z. Murtazina, A. V. Didio, M. P. Serebrenitskaya, V. O. Konstantinov, M. Yu. Mandelshtam, V. B. Vasiliev
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 14, Iss 6, Pp 52-53 (2015)
Clinical case of a patient with family hypercholesterolemia caused by mutation c.1859G>C (p.W620S) in the gene of human low density lipoproteins receptor.
Externí odkaz:
https://doaj.org/article/a43422fb12344776a864c9543e81a2e3